Find-Health-Articles.com - making medical research available to everyone
Research article summary (published May 2009):

Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa.

Full Abstract

The anxiety- and stress-related neuropeptide corticotropin-releasing factor (CRF) elicits behavioral changes in vertebrates including increases in behavioral arousal and locomotor activity. Intracerebroventricular injections of CRF in an amphibian, the roughskin newt (Taricha granulosa), induces rapid increases in locomotor activity in both intact and hypophysectomized animals. We hypothesized that this CRF-induced increase in locomotor activity involves a central effect of CRF on serotonergic neurons, based on known stimulatory actions of serotonin (5-hydroxytryptamine, 5-HT) on spinal motor neurons and the central pattern generator for locomotor activity in vertebrates. In Experiment 1, we found that neither intracerebroventricular injections of low doses of CRF (25 ng) nor the selective serotonin reuptake inhibitor fluoxetine (10, 100 ng), by themselves, altered locomotor activity. In contrast, newts treated concurrently with CRF and fluoxetine responded with marked increases in locomotor activity. In Experiment 2, we found that increases in locomotor activity following co-administration of CRF (25 ng) and fluoxetine (100 ng) were associated with decreased 5-HT concentrations in a number of forebrain structures involved in regulation of emotional behavior and emotional states, including the ventral striatum, amygdala pars lateralis, and dorsal hypothalamus, measured 37 min after treatment. These results are consistent with the hypothesis that CRF stimulates locomotor activity through activation of serotonergic systems.

 

Author information

Author/s: Lowry, Christopher A (CA); Hale, Matthew W (MW); Burke, Kathleen A (KA); Renner, Kenneth J (KJ); Moore, Frank L (FL);

Affiliation: Department of Zoology, Oregon State University, Corvallis, OR 97331, USA. christopher.lowry(-atsign-)colorado.edu

Grants: 1F31MH10288-01A1 (Agency:NIMH NIH HHS) ; MH-44893 (Agency:NIMH NIH HHS)

Journal and publication information

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

Journal: Hormones and behavior (Horm Behav), published in United States. (Language: eng)

Reference: 2009-Jun; vol 56 (issue 1) : pp 177-84

Dates: Created 2009/06/01; Completed 2009/08/21;

PMID: 19409390, status: MEDLINE (last retrieval date: 8/21/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Serotonin Uptake Inhibitors (0) ; Corticosterone (50-22-6) ; Serotonin (50-67-9) ; Hydroxyindoleacetic Acid (54-16-0) ; Fluoxetine (54910-89-3) ; Corticotropin-Releasing Hormone (9015-71-8)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

6/29/1969
8/30/2004
Higher Relevance Score (100)
Lower Relevance Score (65)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index